Pardes Biosciences, Inc. Profile Avatar - Palmy Investing

Pardes Biosciences, Inc.

Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 …

Biotechnology
US, Carlsbad [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of PRDS's Analysis
CIK: 1822711 CUSIP: 69945Q105 ISIN: US69945Q1058 LEI: - UEI: -
Secondary Listings
PRDS has no secondary listings inside our databases.